1790-1791 / 2437
•
Immune checkpoint inhibitors may exert strong
anti-tumor activity
:
=> Melanoma: anti-CTLA-4 alone vs. anti-PD-1 alone
vs. combined treatment
=> Pembrolizumab and nivolumab have been
approved for advanced melanoma and other
tumor entities
•
May these drugs also mount anti-tumor immune
responses against neoplasms in the CNS?
Immune checkpoint inhibitors